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Clinical implications of microvascular
obstruction and intramyocardial
haemorrhage in acute myocardial infarction
using cardiovascular magnetic resonance
imaging
Abstract Objectives To investigate
the clinical implications of
microvascular obstruction (MVO)
and intramyocardial haemorrhage
(IMH) in acute myocardial infarction
(AMI). Methods Ninety patients with a
ﬁrst AMI undergoing primary percuta-
neouscoronaryintervention(PCI) were
studied. T2-weighted, cine and late
gadolinium-enhanced cardiovascular
magnetic resonance imaging was
performedat5±2and103±11days.
Patients were categorised into three
groups based on the presence or
absence of MVO and IMH.
Results MVOwasobservedin54%and
IMH in 43% of patients, and correlated
signiﬁcantly (r=0.8, p<0.001).
Pre-PCI thrombolysis in myocardial
infarction 3 ﬂow was only observed in
MVO(−)/IMH(−) patients. Infarct size
and impairment of systolic function
were largest in MVO(+)/IMH(+)
patients (n=39, 23±9% and 47±7%),
smallest in MVO(−)/IMH(−) patients
(n=41, 8±8% and 55±8%) and
intermediate in MVO(+)/IMH(−)
patients (n=10, 16±7% and 51±6%,
p<0.001). LVEF increased in all three
subgroups at follow-up, but remained
intermediate in MVO(+)/IMH(−)a n d
was lowest in MVO(+)/IMH(+)
patients. Using random intercept model
analysis, only infarct size was an
independent predictor for adverse LV
remodelling. Conclusions Intramyocar-
dial haemorrhage and microvascular
obstruction are strongly related.
Pre-PCI TIMI 3 ﬂow is less frequently
observed in patients with MVO and
IMH. Only infarct size was an
independent predictor of LV
remodelling.
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Introduction
Coronary occlusion that persists for more than 40 min
leads to irreversible myocardial damage that starts in the
endocardium and progresses towards the epicardium as a
wavefront phenomenon [1]. Although timely reperfusion
salvages myocardium and reduces mortality, successful
restoration of epicardial artery patency after prolonged
occlusion does not always lead to adequate reperfusion at
the microvascular level. Reperfused acute myocardial
infarction (AMI) is characterised by myocyte swelling
due to osmotic overload, intracellular calcium overload,
myocyte hypercontraction, microvascular obstruction
(MVO) and intramyocardial haemorrhage (IMH) [2, 3].
Both MVO and IMH occur exclusively in myocardium
that sustains the most severe ischaemia and are therefore
conﬁned to the central portions of infarcted myocardium
[3]. As IMH is caused by extravasation of blood into the
extravascular space as a consequence of ischaemic micro-
vascular damage, it only occurs in reperfused AMI [4, 5].
IMH does not depend on the magnitude of early reﬂow
but, similar to MVO, on the severity of ischaemia as
reﬂected by a longer duration of coronary occlusion and
low collateral ﬂow [6, 7].
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6202 AZ Maastricht, The NetherlandsCardiovascular magnetic resonance imaging (CMR) is
currently regarded as the reference standard to assess
myocardial infarction and allows the detection of MVO
and IMH in vivo, using late gadolinium-enhanced (LGE)
and T2-weighted (T2W) imaging [8–10]. Previous studies
have suggested that MVO might be associated with adverse
ventricularremodellingandclinicaloutcome[9,11–14].The
clinical signiﬁcance of IMH is less well deﬁned, and
conﬂicting results have been reported [15, 16].
In this study, we sought to investigate the clinical
implications of both MVO and IMH with regard to LV
remodelling.
Methods
Study population
We studied 90 consecutive patients (65 men, age 60±
11 years) with a ﬁrst AMI referred for primary percutaneous
coronary intervention (PCI) and presentation <12 h after
symptom onset. The deﬁnition of AMI was based on the
recent consensus document includingappropriate rise and fall
in cardiac biomarkers [17]. Excluded were patients <18 years
and those with contraindications for CMR. The institutional
review board of our hospital approved the study, and patients
were included after written informed consent was obtained.
Before emergency PCI all patients received 500 mg
aspirin,5,000Uheparinand600mgclopidogrel.Theculprit
coronary artery was the LAD in 31%, the RCA in 56% and
LCx in 13% of patients; single vessel disease was present in
52%, two vessel disease in 23% and three vessel disease in
25%. All patients received standard post-PCI care, including
dual antiplatelet therapy for at least 1 month. Thrombosuc-
tion, which was not standard treatment at the time of this
study, and downstream administration of intravenous abcix-
imab,intracoronarynitroglycerineandadenosinewereleftto
the discretion of the interventional cardiologist.
Cardiovascular magnetic resonance imaging protocol
Cardiovascular MRI was performed at 5±2 days and 103±
11 days after admission. Images were acquired on a 1.5-T
MRI system (Intera, Philips Medical Systems, Best, The
Netherlands) with a dedicated ﬁve-element phased array
surface coil. For functional analysis, ECG-gated cine images
were obtained in the LV short axis plane covering the entire
LV using a segmented balanced steady-state free precession
sequence [slice thickness 6 mm, slice gap 4 mm, average
repetition time (TR) and echo time (TE) 3.8/1.9 ms,
respectively, ﬂip angle 50°, FOV 350 mm, matrix 256×
256, typically 22–25 phases per cardiac cycle]. Next, a
breath-hold, multislice, black blood T2-weighted turbo spin-
echo sequence with short inversion time and fat suppression
was used (T2 STIR, slice thickness 8 mm, slice gap 2 mm,
TR two R-R intervals and TE 100 ms, FOV 350 mm, matrix
512×512). LGE CMR was performed 10 min after an
intravenous bolus of 0.2 mmol/kg body weight gadolinium-
diethylenetriaminepentaacetic acid (Magnevist®, Bayer
Schering Pharma, Berlin, Germany) using a breath-hold
three-dimensional inversion-recovery gradient-echo
sequence [acquired slice thickness 12 mm, reconstructed
slice thickness 6 mm, average TR/TE 3.9/2.4 ms, multi-shot
(50 proﬁles/shot) segmented partialecho readout every heart
beat (TFE), ﬂip angle 15°, FOV 400 mm, matrix 256×256,
acquired and reconstructed pixel size 1.56×1.56 mm]. The
inversion time that optimally suppressed signal of non-
infarcted myocardium (typical range 200–280 ms) was
determined with a preceding Look-Locker sequence.
CMR image analysis
The CMR images were analysed independently by two
observers blinded to clinical data, using commercially
available software (CAAS MRV 3.0, Pie Medical Imaging,
Maastricht, The Netherlands). The interobserver agreement
was excellent (κ value 0.9). Discrepancies were resolved in
consensus. Endocardial and epicardial borders were man-
ually traced, excluding the papillary muscles, in the end-
diastolic and end-systolic short-axis phases to determine left
ventricular end-diastolic volume (LVEDV), end-systolic
volume (LVESV), stroke volume (LVSV), ejection fraction
(LVEF)andend-diastolicmass(LVmass).Theseparameters
were indexed for body surface area.
Likewise, endocardial and epicardial contours were
manually traced on the LGE and T2 images, which were
viewed as separate sets. The T2W images of the ﬁrst CMR
examination were used to determine the presence or
absence of IMH, deﬁned as a central hypoenhanced area
within the hyperintense oedematous area, indicative of the
area at risk (AAR). The AAR was quantiﬁed by semi-
automatic detection using a signal intensity (SI) threshold
of >2 SD above a remote non-infarcted region and
expressed as a percentage of LV mass. Subendocardial
‘slow ﬂow’ artefacts were carefully excluded, and areas of
IMH were included in the AAR analysis by manual
adjustment of contours. IMH was manually traced and
expressed as a percentage of LV mass.
Infarct size (IS) was quantiﬁed on the LGE images of the
ﬁrst CMR using an SI threshold of >5 SD above a remote
non-infarcted reference region, including areas of MVO
(central hypoenhancement within hyperenhanced area) and
expressed as a percentage of LV mass. MVO was quantiﬁed
by manually tracing the central hypoenhanced area and
expressed as a percentage of LV mass.
Statistics
Summary statistics of continuous data with symmetric
distribution are expressed as mean ± standard deviation
(SD), otherwise as median with interquartile range (IQR).
2573Categorical data are expressed as frequencies with percen-
tages. Univariate group comparisons were conducted with
the one-way ANOVA or the non-parametric Kruskal-Wallis
test for continuous variables. For categorical variables, chi-
square or Fisher’s exact tests were applied. Adjustment for
multiple testing was conducted via the false discovery rate
(FDR). Detected differences were considered signiﬁcant
whenthe correctedFDR p value was <0.05. A multiple OLS
linear regression model was ﬁtted to quantify the association
between IMH and MVO for the MVO(+)/IMH(+) group,
adjusting for other clinical variables. To stabilise residual
variance, IMH and MVO values, expressed as a proportion
of the LV mass, were logarithmically transformed (ln). The
ﬁnal model was used to predict IMH size for the remaining
10 MVO(+)/IMH(−) patients. The estimated IMH values
could provide some indication of the possible underlying
reasons for the absence of IMH in these patients. A random
intercept model analysis was conducted to determine
independent predictors of LV remodelling. Statistical anal-
ysis was performed with SPSS software (version 17.0 for
Windows; SPSS Inc., Chicago, IL).
Results
IMH and MVO
Signal intensity on the T2W and LGE images within the
territory of the IRA was increased in all patients. The AAR
and IS were 26±12% and 15±11% of LV mass, respectively.
MVO was observed in 49 (54%) and IMH in 39 patients
(43%), and both were always located subendocardially within
the infarct core. IMH was only observed in patients with
MVO.AsigniﬁcantcorrelationwasfoundbetweenMVOand
IMH extent (r=0.8, p<0.001, Fig. 1), but absolute MVO
extent was larger than that of IMH [3.1 ml (IQR 1.6–5.3) vs.
2.2 ml (IQR 1.6–3.5), p=0.04].
Subgroups
Based on the presence or absence of MVO and IMH,
patients were classiﬁed into three groups: 41 patients with
MVO(−)/IMH(−), 10 with MVO(+)/IMH(−) and 39 with
MVO(+)/IMH(+) (Fig. 2). For most of the baseline
characteristics, there were no signiﬁcant differences
between groups (Table 1), except for pre-PCI TIMI 3
ﬂow, which was only observed in the MVO(−)/IMH(−)
group. There was no difference in the use of glycoprotein
IIbIIIa inhibitor between groups.
The AAR and IS were largest in the MVO(+)/IMH(+)
group, intermediate in the MVO(+)/IMH(−) group and
smallestintheMVO(−)/IMH(−)group(Table1).Myocardial
salvage, deﬁned as the difference between AAR and IS, was
lowest in the MVO(+)/IMH(+) group, intermediate in the
MVO(+)/IMH(−) group and highest in the MVO(−)/IMH(−)
group (28±24%, 40±25% and 54±32%, respectively, p<
0.001, Table 1 and Fig. 3).
The MVO extent tended to be larger in the MVO(+)/IMH
(+) patients compared with the MVO(+)/IMH(−) patients
[1.7% (IQR 1.0–3.3%) vs. 0.8% (IQR 0.4–1.9%) of LV
mass, respectively, p=0.07].
Predicted IMH size in patients with MVO but without IMH
The IMH in the MVO(+)/IMH(−) patients could have
been missed as a result of the limits of spatial resolution of
T2W CMR. To investigate this, predicted IMH size values
for MVO(+)/IMH(−) were calculated based on the
Fig. 1 Correlation between IMH and MVO. a Original scale values. b
Logtransformedvalues.A goodlinearcorrelationisseenbetweenMVO
and IMH (r=0.86, p<0.001). Open circles indicate observed values and
stars indicate predicted values in the MVO(+)/IMH(-) group. Note that
most of the predicted values are within the lower range of observed
values
2574following model derived from the MVO(+)/IMH(+) group
data:
ln IMH ¼  0:348 þ 0:718  ln MVO þ 0:454 sexþ ½
0:395 smoke :
All predictors in the above model were statistically
signiﬁcant. Observed and predicted IMH values are
displayed in Fig. 1a and b. Predicted values are marked
as stars. In either case it is evident that only two patients
had sufﬁciently small predicted IMH outside the observed
value range in the other patients. Theoretically, these two
values could have been missed by T2W CMR. Con-
versely, several of the predicted values were still of
sufﬁcient size, at least comparable to that of the observed
counterparts, and as such they could have been detected
by CMR.
Functional parameters and LV remodelling
The LVEDVi and LVESVi decreased from baseline to
follow-up and were highest in the MVO(+)/MVO(+) group,
intermediateintheMVO(+)/IMH(−)groupandlowestinthe
MVO(−)/IMH(−) group at both time points (Table 2).
Likewise, LVEF improved in all three groups, but remained
lowest in the MVO(+)/MVO(+) group, intermediate in the
MVO(+)/IMH(−) group and highest inthe MVO(−)/IMH(−)
group in the univariate comparisons (Fig. 4).
Table 3 displays the ﬁxed effect parameter estimates of
the random intercept model. Subjects were taken as
random effect, whereas time and MVO/IMH groups were
taken as ﬁxed effect factors adjusted for IS. LVEF
signiﬁcantly increased over time (for all groups), showing
a signiﬁcant negative association with IS. Note that the
presence of IMH or MVO had no signiﬁcant independent
predictive value for LVEF once adjusted for IS.
Fig. 2 Magnetic resonance
image examples from each
patient group. Top row (a, b):
MVO(−)/IMH(−) patient;
middle row (c, d): MVO(+)/
IMH(−) patient; bottom row
(e, f): MVO(+)/(IMH(+)
patient. T2-weighted images
are shown on the left (a, c, e)
and corresponding late
gadolinium-enhanced images
on the right (b, d, f). Oedema
and infarct border zones are
indicated by arrowheads and
IMH and MVO by asterisks
2575Discussion
The ﬁndings of our study can be summarised as follows:
(1) MVO and IMH are frequently observed in reperfused
AMI using T2W and LGE CMR, (2) IMH and MVO are
strongly related phenomena, (3) patients with MVO and
IMH have pre-PCI TIMI 3 ﬂow less often, and (4) infarct
size, once adjusted for MVO and IMH presence, remained
the sole independent predictor of LV remodelling.
T2W CMR is capable of detecting myocardial oedema
as regions of increased signal intensity due to prolonga-
tion of T2 relaxation time as a consequences of increased
tissue free water content [18]. IMH is thought to be caused
by leakage of blood out of severely injured micro-
vasculature into the interstitium that can be depicted as a
central area of low signal intensity (SI) within the
oedematous area on T2W CMR. This low SI is explained
by local ﬁeld heterogeneities due to the paramagnetic
effects of blood degradation products such as deoxyhae-
moglobin, which shorten the T2 relaxation time [10]. In
two case reports, Basso et al. demonstrated a good
correlation among the location, spatial extent, and shape
of IMH on CMR and histopathology [8]. Because of its
excellent spatial resolution and high contrast, LGE CMR
accurately assesses the extent of infarction and MVO [19].
Combined with T2W CMR, it is now possible to gain
novel insights into the pathophysiology of IMH and MVO
in vivo and evaluate their clinical signiﬁcance.
Previous studies have shown that MVO infarcts show a
lack of regional and global functional recovery compared
with non-MVO infarcts; however, it remains unclear
whether MVO provides independent prognostic informa-
tion [11, 12]. Despite the strong relation of MVO with IS,
some studies indicated that MVO is an important
determinant of LV recovery and prognosis, even after
controlling for IS, whereas others have reported that MVO
loses its predictive power after adjusting for IS [13, 14,
20, 21]. Persistence of MVO, but not MVO that
disappeared at 1 week after infarction, was associated
with attenuated infarct healing and subsequent adverse
remodelling, indicating that the timing of MVO imaging is
important [22]. In that study and similar to our ﬁndings, IS
remained the major determinant of LV remodelling in a
multivariate model.
Fig. 3 Area at risk (AAR) and infarct size (IS). AAR (grey bars) and
IS (white bars) represented as percentages of LV mass for each patient
group. The MVO(+)/IMH(−) group represents an intermediate group.
Myocardial salvage is the difference between AAR and IS
Table 1 Baseline characteristics
Group FDR p value
MVO(−)/IMH(−) (n=41) MVO(+)/IMH(−) (n=10) MVO(+)/IMH(+) (n=39)
Age (years) 61±9 59±15 59±12 0.64
Male (%) 27 (66) 6 (60) 32 (82) 0.29
DM (%) 4 (10) 1 (10) 1 (3) 0.49
Smoking (%) 33 (80) 9 (90) 36 (92) 0.38
Hypertension (%) 20 (49) 3 (30) 12 (31) 0.35
Hypercholesterolaemia (%) 11 (27) 3 (30) 11 (28) 0.95
Positive family history (%) 16 (39) 3 (30) 22 (56) 0.29
Anterior location (%) 10 (24) 2 (20) 16 (41) 0.30
Previous angina (%) 13 (32) 3 (30) 21 (54) 0.20
GIIbIIIa inhibitor (%) 17 (41) 5 (50) 23 (59) 0.38
TIMI 3
Pre-PCI (%) 10 (24) 0 (0) 0 (0) 0.004
Post-PCI (%) 36 (88) 9 (90) 35 (90) 0.66
Rentrop ≥2 (%) 9 (22) 5 (50) 7 (18) 0.20
Thrombosuction (%) 9 (22) 2 (20) 11 (28) 0.89
Time to PCI (min) 217 (165–304) 177 (148–248) 201 (160–291) 0.65
AAR (%) 19±12
1.2 27±8
1 33±9
2 <0.001
IS (%) 8±8
3.4 16±7
3.5 23±9
4.5 <0.001
Myocardial salvage (%) 54±32
6 40±25 28±24
6 0.004
MVO (% of LV mass) 0 0.8 (0.4–1.9) 1.7 (1.0–3.3) 0.07
IMH (% of LV mass) 0 0 1.6 (1.0–2.4)
Values are presented as mean ± SD or median and IQR; AAR: area at risk; DM: diabetes mellitus; IS: infarct size at baseline; IHM: intramyocardial
haemorrhage; MVO: microvascular obstruction; PCI: percutaneous coronary intervention. Superscripts indicate signiﬁcant post-hoc, pairwise comparisons
2576Our clinical observation that MVO and IMH occur in
the central portions of the infarct and not in patients
with pre-PCI TIMI 3 ﬂow is in line with experimental
studies showing the association of IMH with markedly
depressed ﬂow before reperfusion and severe ischaemia
[5]. Our ﬁnding that IMH was also observed in 10% of
patients with post-PCI TIMI ﬂow <3 supports exper-
imental observations that IMH does not depend on the
magnitude of early reﬂow [6, 23]. Conﬂicting results on
the clinical signiﬁcance of IMH have been reported.
Our data are in contrast to those of Ganame et al., who
found that LVEF did not improve in patients with
haemorrhagic infarcts as opposed to patients with non-
haemorrhagic infarcts [16]. IMH and infarct size were
the strongest independent predictors of adverse LV
remodelling in that study. Our results are in accordance
with those from Beek et al., who showed that IMH did
not have prognostic signiﬁcance beyond the presence of
MVO [15].
The underlying pathophysiological mechanisms of
MVO and IMH are complex and remain only partially
understood. Irreversible ischaemic myocardial cell
injury progresses as a ‘wave front’ from the endocar-
dium to the epicardium, with endothelial cell injury
occurring after myocardial cell injury [1, 3]. After
varying periods of ischaemia, sequential changes of the
microvasculature occur. Endothelial protrusion by cell
swelling together with capillary plugging by neutro-
phils, red blood cells and platelets and swelling of
surrounding myocytes compressing capillaries may all
cause MVO. As ischaemic injury progresses, endothe-
lial cell death causes loss of capillary integrity with
resultant IMH in cases of myocardial reperfusion. Our
data show that MVO and IMH are strongly related
phenomena and suggest that IMH is a sign of severely
injured microvasculature that easily leaks blood into the
interstitial space. Furthermore, our results suggest that
microvascular injury is predominantly a reﬂection of
extensive myocardial necrosis rather than a separate
entity identifying patients at higher risk.
Despite having MVO, IMH was absent in ten
patients in our study. We postulate that, for some
patients in the MVO(+)/IMH(−) group, the ischaemic
threshold for IMH may not have been reached yet. This
could explain the discrepancy between the predicted
IMH values and the negative ﬁndings at CMR. Lending
support to this concept was the ﬁnding that all
measured parameters, including MVO size, were in
between the average values of the two other groups. It
is therefore likely that the groups reﬂect a gradation of
the severity of ischaemic damage.
Fig. 4 Left ventricular ejection fraction (LVEF) at baseline and
follow-up. LVEF signiﬁcantly increased in all three groups from
baseline (grey bars) to follow-up CMR (white bars), but remained
intermediate in the MVO(+)/IMH(−) group
Table 3 Fixed effect parameter estimates of the random intercept
model. Outcome variable: LVEF
β (SE) p value
Intercept 55.651 (2.086) <0.001
IS −0.452 (0.071) <0.001
Time 2.660 (0.623) <0.001
MVO(−)/IMH(−) −0.023 (1.648) 0.989
MVO(+)/IMH(−) 0.004 (2.059) 0.998
MVO(+)/IMH(+) Reference
IS: infarct size. Error and random intercept variances were 15.762 and
20.571, respectively (p<0.001)
Table 2 Functional parameters at baseline and follow-up
Group FDR p value
MVO(−)/IMH(−) (n=41) MVO(+)/IMH(−) (n=10) MVO(+)/IMH(+) (n=39)
LVEDVi (ml/m
2)
Baseline 81±14
1 86±15 88±17
1 0.24
Follow-up 78±18
2 76±12 88±20
2 0.13
LVESVi (ml/m
2)
Baseline 38±11
3 43±11 47±13
3 0.01
Follow-up 34±12
4 34±6 45±15
4 0.01
LVEF (%)
Baseline 55±8
5 51±6 47±7
5 <0.001
Follow-up 57±7
6 55±3 50±7
6 <0.001
Values are presentedasmean ± SD; IMH: intramyocardial haemorrhage; LVEDVi: left ventricular enddiastolic volume index; LVESVi: left ventricularend-systolic
volume index; LVEF: left ventricular ejection fraction; MVO: microvascular obstruction. Superscripts indicate signiﬁcant post-hoc, pairwise comparisons
2577Conclusions
Microvascular obstruction and intramyocardial haemorrhage
are frequently observed in reperfused AMI using T2W and
LGE CMR, and are strongly related phenomena. Patients
with MVO and IMH have pre-PCI TIMI 3 ﬂow less often,
suggesting more severe ischaemia before reperfusion. Only
infarct size, but not the presence of IMH or MVO, was an
independent predictor for LVEF. This suggests that MVO and
IMH are not just separate entities, but rather ischaemia-
dependentconsequencesofseverelyinjuredmicrovasculature
in larger infarcts.
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